T1	Participants 521 570	Consecutive children with lymphoblastic leukaemia
T2	Participants 719 733	(748 patients)
T3	Participants 789 797	patients
T4	Participants 1316 1333	treatment groups.
T5	Participants 1653 1664	95 patients
T6	Participants 1722 1724	82
T7	Participants 1788 1811	-thioguanine recipients
